Abstract. MIRANDA GARCIA, Mª C.. Extended spectrum beta-lactamase – positive Escherichia coli: resistance. Sanid. Mil. [online]. , vol, n.4, pp Tratamiento de las infecciones por microorganismos productores de betalactamasas de espectro extendido: un nuevo reto terapéutico. Prevalencia de betalactamasas de espectro extendido en Escherichia coli, Klebsiella pneumoniae y Klebsiella oxytoca del Hospital Occidente de Kennedy.

Author: Faurr Tozil
Country: Burkina Faso
Language: English (Spanish)
Genre: Travel
Published (Last): 17 October 2015
Pages: 218
PDF File Size: 12.89 Mb
ePub File Size: 19.11 Mb
ISBN: 227-9-12295-150-2
Downloads: 94816
Price: Free* [*Free Regsitration Required]
Uploader: Mazulrajas

Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: ESBL production was confirmed by both methods in 47 Enterobacteriaceae9.

Braz J Infect Dis. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection. Global distribution of the HRx sublineage. Todos los pacientes enrolados dieron su consentimiento mediante un documento escrito. Prevalence of beta-lactamase CTX-M in phylogenetic groups of uropathogenic Escherichia coli isolated from patients in the community of Merida, Venezuela. Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia.

Risk factors and clinical impact of levo-floxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. A case-control study was conducted between August and December of in betalactamassas Colombian tertiary-care institutions.

Results Of the recruited patients, had a positive urine especto, of which grew E. The objective was to determine the frequency of ESBL producing Enterobacteriaceae in outpatient and hospitalized patients at the San Roque laboratory from September to November Waging war against uropathogenic Escherichia coli: Among clinical isolates of Enterobacteriaceae Dissemination of clonally related Escherichia coli espectrk expressing extended-spectrum beta-lactamase CTX-M Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.


En los aislamien-tos de E. Manuscrit de l’auteur; accessible dans PMC nov.

Resistant gram-negative infections in the outpatient setting in Latin America. Las ITU causadas por E. Int J Clin Pract.

Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Un total de 2. An emerging public-health concern.

There was a problem providing the content you requested

Resultados De los 2. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: Expert Rev Anti Infect Ther. Winning back the urinary tract. We conducted a cross-sectional descriptive observational study. Please review our privacy policy.

Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum beta-lactamase in a large U. Enferm Infecc Microbiol Clin. Open in a separate window.

Existen algunos factores asociados a la presencia de ITU por bacterias productoras de BLEE en la comunidad ce en la literatura, y entre estos destacan: Break-down of antibiotic prescription in health centres by infection concerned.

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E.


Author information Copyright and License information Disclaimer. Spanish pdf Article in xml format Article references How to cite this article Automatic translation Send this article by e-mail.

Escherichia coli portador de betalactamasas de espectro extendido: resistencia

Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections. Nursing homes as a reservoir of extended-spectrum beta-lactamase ESBL -producing ciprofloxacin-resistant Escherichia coli. The majority of ESBL isolates were susceptible to ertapenem, phosphomycin and amikacin.

Epidemiology and risk factors of community onset infections caused by extended-spectrum beta-lactamase-producing Escherichia coli strains. Support Center Support Center. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.

Of the recruited patients, had a positive urine culture, of which grew E. International prospective study of Klebsiella pneumoniae bacteremia: Curr Opin Infect Dis. Emergence of CTXMproducing strains causing urinary tract infections. Characterization, epidemiology, and detection of this important resistance threat. Materials and methods A case-control study was conducted between August and December of in three Colombian tertiary-care institutions. However, information of resistant isolates in this context is limited in Latin America.

Int J Antimicrob Agents.